OK, you’ve got me — this video is TOO slick. It makes your average YouTube video look like it was drawn in crayon by a five-year-old. Of course, it was created by Novartis, and the pharmas are the kings of slick media production.
I’m sharing this with you not because it says anything novel, though it does bring together some very compelling statistics on the impact of preventable health conditions.
No, I’m passing it along because marketers and strategists out there might find its (comparatively) soft-sell approach to the value of pharma R&D to be rather interesting. With social media demanding a new approach to reaching audiences — a voice that suggests and guides, rather than pitches — expect to see pharmas do a lot more indirect selling.
Related articles by Zemanta
- Pharma and Social Media: The Starting Points (scienceroll.com)
- YouTube and Pharma: An Update (biojobblog.com)
- Pharma comms chief warns healthcare PR professionals of social media pitfalls (prweek.com)
- Social Media and Pharma: Adverse Events Reporting Revisited (biojobblog.com)
- Social Media Offers Pharma, Physicians Opportunities for Better Interaction with Consumers (thoughtleaderselect.wordpress.com)